Stock Research for CERS

CERS

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

CERS Stock Chart & Research Data

The CERS chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CERS chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


CERS Due diligence Resources & Stock Charts

The CERS stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View CERS Detailed Price Forecast - CNN Money CNN View CERS Detailed Summary - Google Finance
Yahoo View CERS Detailed Summary - Yahoo! Finance Zacks View CERS Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View CERS Trends & Analysis - Trade-Ideas Barrons View CERS Major Holders - Barrons
NASDAQ View CERS Call Transcripts - NASDAQ Seeking View CERS Breaking News & Analysis - Seeking Alpha
Spotlight View CERS Annual Report - CompanySpotlight.com OTC Report View CERS OTC Short Report - OTCShortReport.com
TradeKing View CERS Fundamentals - TradeKing Charts View CERS SEC Filings - Bar Chart
WSJ View Historical Prices for CERS - The WSJ Morningstar View Performance/Total Return for CERS - Morningstar
MarketWatch View the Analyst Estimates for CERS - MarketWatch CNBC View the Earnings History for CERS - CNBC
StockMarketWatch View the CERS Earnings - StockMarketWatch MacroAxis View CERS Buy or Sell Recommendations - MacroAxis
Bullish View the CERS Bullish Patterns - American Bulls Short Pains View CERS Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View CERS Stock Mentions - StockTwits PennyStocks View CERS Stock Mentions - PennyStockTweets
Twitter View CERS Stock Mentions - Twitter Invest Hub View CERS Investment Forum News - Investor Hub
Yahoo View CERS Stock Mentions - Yahoo! Message Board Seeking Alpha View CERS Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for CERS - SECform4.com Insider Cow View Insider Transactions for CERS - Insider Cow
CNBC View CERS Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for CERS - OTC Markets
Yahoo View Insider Transactions for CERS - Yahoo! Finance NASDAQ View Institutional Holdings for CERS - NASDAQ


Stock Charts

FinViz View CERS Stock Insight & Charts - FinViz.com StockCharts View CERS Investment Charts - StockCharts.com
BarChart View CERS Stock Overview & Charts - BarChart Trading View View CERS User Generated Charts - Trading View




Latest Financial News for CERS


American Red Cross Receives Biologics License Application Approval For INTERCEPT Platelets
Posted on Monday December 10, 2018

Cerus Corporation (CERS) announced today that the American Red Cross has received approval by the U.S. Food and Drug Administration (FDA) for their first biologics license application (BLA) for interstate distribution of platelets that have been pathogen-reduced with INTERCEPT Blood Systems. “This BLA approval is a key milestone for Cerus and the American Red Cross,” said Vivek Jayaraman, Cerus’ chief commercial officer.


Cerus Supports FDA’s Continuing Efforts to Enhance the Safety of the U.S. Platelet Supply
Posted on Tuesday December 04, 2018

Cerus Corporation announced today the issuance of a new U.S. Food and Drug Administration draft guidance document on bacterial risk control strategies for platelet collection and transfusion.


Does Cerus Corporation (NASDAQ:CERS) Have A Particularly Volatile Share Price?
Posted on Thursday November 15, 2018

If you’re interested in Cerus Corporation (NASDAQ:CERS), then you might want to consider its beta (a measure of share price volatility) in order to understand how the stock could impact


Report: Developing Opportunities within Lexicon Pharmaceuticals, Cray, RCI Hospitality, Sanmina, Diamond Offshore Drilling, and Cerus — Future Expectations, Projections Moving into 2018
Posted on Monday November 12, 2018

NEW YORK, Nov. 12, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.